GlaxoSmithKline Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on October 30, 2009, inter alia, to consider, approval of unaudited financial results for the 3rd quarter June-September 2009 (Q3).
| NIFTY 
